Among these new targets, the stimulation ... Subthalamic nucleus stimulation is an effective treatment for motor complications and dyskinesia in Parkinson's disease, but is less effective on ...

Researchers have identified that G-quadruplexes promote harmful protein aggregation in neurodegenerative diseases. Blocking ...

which could lead to treatments for the cognitive symptoms of Parkinson's disease ... New Drug Targets for Alzheimer's Identified from Cerebrospinal Fluid Nov. 14, 2024 — Researchers have linked ...

There's an enormous market of patients who could potentially qualify for focused ultrasound treatment. Experts report about 1 million people in the United States alone are living with Parkinson's ...

Cerevance has initiated the Phase 3 ARISE trial to evaluate solengepras as a potential adjunctive treatment for Parkinson's ...

Scientists at La Trobe University have created a world-first method to investigate "disordered" proteins in living cells, in ...

NEW DELHI: Long-term exposure to antibiotics may significantly raise the risk of Parkinson's disease, finds a study. To ...

The procedure, using focused ultrasound technology, was performed at the Norton Neuroscience Institute, making it the first ...

Parkinson’s disease is a brain disorder that affects about one million people in the U.S. It happens when the brain loses ...

Parkinson’s disease is a progressive neurological condition that affects millions of people worldwide. While most treatments ...

ImPULS generates high-frequency sound waves to activate brain cells and help reconnect broken circuits and, ultimately, help ...

According to the new study, patients with a slow progression ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a ...